SG Americas Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.5M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $35.9M | Buy |
|
|||||
|
2024
Q4 | $392K | Sell |
|
|||||
|
2024
Q3 | $932K | Buy |
|
|||||
|
2024
Q2 | $106K | Sell |
|
|||||
|
2024
Q1 | $5.79M | Buy |
|
|||||
|
2023
Q4 | $126K | Sell |
|
|||||
|
2023
Q3 | $3.51M | Buy |
|
|||||
|
2023
Q2 | $724K | Sell |
|
|||||
|
2023
Q1 | $2.34M | Buy |
|
|||||
|
2022
Q4 | $1.61M | Buy |
|
|||||
|
2022
Q3 | $244K | Sell |
|
|||||
|
2022
Q2 | $2.03M | Sell |
|
|||||
|
2022
Q1 | $4.57M | Buy |
|
|||||
|
2021
Q4 | $1.5M | Sell |
|
|||||
|
2021
Q3 | $2.06M | Sell |
|
|||||
|
2021
Q2 | $3.23M | Buy |
|
|||||
|
2021
Q1 | $379K | Buy |
|
|||||
|
2020
Q4 | $297K | Sell |
|
|||||
|
2020
Q3 | $467K | Sell |
|
|||||
|
2020
Q2 | $2.04M | Buy |
|
|||||
|
2020
Q1 | $407K | Buy |
|
|||||
|
2019
Q4 | $373K | Buy |
|
|||||
|
2019
Q3 | $143K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $12.5M | Buy |
|
|||||
|
2018
Q4 | $1.44M | Buy |
|
|||||
|
2018
Q3 | $825K | Buy |
|
|||||
|
2018
Q2 | $471K | Sell |
|
|||||
|
2018
Q1 | $2.73M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $181K | Sell |
|
|||||
|
2017
Q2 | $8.55M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $849K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $353K | Buy |
|
|||||
|
2016
Q1 | $304K | Buy |
|
|||||
|
2015
Q4 | $362K | Sell |
|
|||||
|
2015
Q3 | $505K | Sell |
|
|||||
|
2015
Q2 | $1.74M | Buy |
|
|||||
|
2015
Q1 | $454K | Sell |
|
|||||
|
2014
Q4 | $1.63M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $526K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $702K | Buy |
|